CWM
PGNX

Cornerstone Wealth Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Cornerstone Wealth Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,697
Closed -$520K – 1247
2018
Q3 		$520K Sell
3,697
-525
-12% -$73.8K 0.01% 904
2018
Q2 		$520K Buy
+4,222
New +$520K 0.01% 999